Free Trial

Raia Drogasil (OTCMKTS:RADLY) Shares Down 11.6% - Time to Sell?

Raia Drogasil logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Shares fell 11.6% on Wednesday to $4.03 (from a prior close of $4.56), trading as low as $4.03 during mid-day action.
  • Volume was extremely light at about 380 shares, a 98% decline from the average daily volume, and the stock is trading below both its 50‑day ($4.78) and 200‑day ($4.31) moving averages, indicating thin liquidity and bearish technicals.
  • Raia Drogasil is a leading Brazilian retail pharmacy operator (stores under the Raia and Drogasil banners) formed by the 2011 merger of Drogasil and Droga Raia.
  • MarketBeat previews top five stocks to own in May.

Raia Drogasil S.A. (OTCMKTS:RADLY - Get Free Report)'s share price dropped 11.6% during mid-day trading on Wednesday . The company traded as low as $4.03 and last traded at $4.03. Approximately 380 shares changed hands during trading, a decline of 98% from the average daily volume of 21,993 shares. The stock had previously closed at $4.56.

Raia Drogasil Price Performance

The company's 50-day simple moving average is $4.78 and its 200 day simple moving average is $4.31.

About Raia Drogasil

(Get Free Report)

Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.

The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Raia Drogasil Right Now?

Before you consider Raia Drogasil, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Raia Drogasil wasn't on the list.

While Raia Drogasil currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2026 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines